Scarring in glaucoma filtration surgical procedures
- Type
- Particular clinical situation in a disease or syndrome
- Group
- Disorder
- Inheritance
- Not applicable
- Age of onset
- All ages
- Status
- active
A rare ophthalmic condition characterized by formation of excessive scar tissue between the conjunctiva/Tenon capsule and the sclera at the surgical site following glaucoma filtration surgery. Scarring can occur months or years after surgery, resulting in treatment failure with poor postoperative control of intraocular pressure and, potentially, loss of vision.
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | Scarring in glaucoma filtration surgical procedures | |
| fr | Cicatrisation post-chirurgicale du glaucome | |
| de | Vernarbung nach filtrierender Glaukomchirurgie | |
| es | Cicatrización tras cirugía de filtración de glaucoma | |
| it | Cicatrizzazione postchirurgica del glaucoma | |
| nl | Littekenvorming bij filtrerende glaucoomchirurgie | |
| pt | Cicatrização pós-cirurgia filtrante do glaucoma | |
| pl | Bliznowacenie po chirurgicznej operacji jaskry | |
| cs | Jizvení po trabekulektomii pro glaukom | |
| uk | Рубці при фільтраційних хірургічних процедурах при глаукомі | |
| zh | 青光眼滤过手术后瘢痕化 | |
| tr | Glokom filtrasyon cerrahi prosedürlerinde yara izi |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| ICD-10 | H59.8 | NTBT | attributed | validated |
| ICD-11 | 9D22 | NTBT | attributed | validated |
| UMLS | C5681395 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:519329Rare disorder involving multiple structures of the eye
rare ophthalmic disorders
No children.
Genes
0 directOrphanet records no gene directly on this code.
Prevalence and incidence
1 record| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Point prevalence | 1-5 / 10 000 | 22 / 100 000 | Europe | Value and class | Validated | European Medicines Agency[OTHER] |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
Orphanet has no HPO annotation for this code in this release.
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/90080
- This record as JSON: /data/d/90080.json